Activist 13D/13G Filings - XOMA ROYALTY CRP DEP REPSTG 1/ (XOMAO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-09
10:05 am
Sale		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		FMR LLC1,155,033
10.054%		-91,653decrease
(-7.35%)		View
2024-01-16
5:22 pm
Purchase		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P3,633,743
31.600%		103,200increase
(+2.92%)		View
2023-02-09
12:46 pm
Purchase		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		FMR LLC1,246,686
10.887%		83,598increase
(+7.19%)		View
2022-08-10
08:10 am
Purchase		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		FMR LLC1,163,088
10.183%		275,566increase
(+31.05%)		View
2022-02-14
5:20 pm
Sale		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		Eagle Point Credit Management LLC0
0.000%		-149,248decrease
(Position Closed)		View
2022-02-09
10:04 am
Purchase		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		FMR LLC887,522
7.846%		887,522increase
(New Position)		View
2021-04-19
4:53 pm
Purchase		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		Eagle Point Credit Management LLC149,248
6.300%		149,248increase
(New Position)		View
2021-04-02
5:16 pm
Sale		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P3,530,543
31.400%		-651,700decrease
(-15.58%)		View
2020-12-15
5:21 pm
Unchanged		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P4,182,243
37.900%		0
(Unchanged)		View
2020-10-09
5:20 pm
Unchanged		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P4,182,243
38.000%		0
(Unchanged)		View
2020-09-23
5:28 pm
Purchase		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P4,182,243
38.000%		156,086increase
(+3.88%)		View
2020-08-19
4:31 pm
Unchanged		13GXOMA ROYALTY CORP 8.625% PERP
XOMAP		NOVARTIS AG
NVS		539,131
4.900%		0
(Unchanged)		View
2020-04-17
4:54 pm
Purchase		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P4,026,157
36.600%		12,703increase
(+0.32%)		View
2020-03-17
9:26 pm
Purchase		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P4,013,454
36.400%		118,277increase
(+3.04%)		View
2020-02-13
5:30 pm
Purchase		13DXOMA ROYALTY CORP 8.625% PERP
XOMAP		BIOTECHNOLOGY VALUE FUND L P3,895,177
35.400%		1,252,772increase
(+47.41%)		View